Related references
Note: Only part of the references are listed.Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications
Chris Stockmann et al.
CLINICAL PHARMACOKINETICS (2014)
Population Pharmacokinetics of Intravenous Acyclovir in Preterm and Term Infants
Mario R. Sampson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Considerations in the Pharmacologic Treatment and Prevention of Neonatal Sepsis
Chris Stockmann et al.
PEDIATRIC DRUGS (2014)
Drug Labeling and Exposure in Neonates
Matthew M. Laughon et al.
JAMA PEDIATRICS (2014)
Do we really need continuous vancomycin infusion in neonates?
Samira Samiee-Zafarghandy et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2013)
Vancomycin use in neonates and children: evidence-based practice is needed
Helen M. Sammons et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2013)
Continuous infusion of vancomycin in neonates
Anisa D. Patel et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2013)
External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings
Wei Zhao et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Neonatal Herpes Simplex Virus Infections
Swetha G. Pinninti et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2013)
Neonatal Infectious Diseases Evaluation of Neonatal Sepsis
Andres Camacho-Gonzalez et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2013)
Desired Vancomycin Trough Serum Concentration for Treating Invasive Methicillin-resistant Staphylococcal Infections
Adam Frymoyer et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Improved Vancomycin Dosing in Children Using Area Under the Curve Exposure
Jennifer Le et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Vancomycin Dosing in Children and Young Adults: Back to the Drawing Board
Lauren Camaione et al.
PHARMACOTHERAPY (2013)
Population Pharmacokinetics of Intermittent Vancomycin in Children with Cystic Fibrosis
Chris Stockmann et al.
PHARMACOTHERAPY (2013)
Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration
Evelyne Jacqz-Aigrain et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2013)
Extended interval dosing of gentamicin in premature neonates=28-week gestation
Belal Alshaikh et al.
ACTA PAEDIATRICA (2012)
Staphylococcus aureus, including Community-Acquired Methicillin-resistant S. aureus, in a Level III NICU: 2001 to 2008
Divya Rana et al.
AMERICAN JOURNAL OF PERINATOLOGY (2012)
Echinocandin Use in the Neonatal Intensive Care Unit
Kelly E. Caudle et al.
ANNALS OF PHARMACOTHERAPY (2012)
Pharmacokinetic-Pharmacodynamic Model for Gentamicin and Its Adaptive Resistance with Predictions of Dosing Schedules in Newborn Infants
Ami F. Mohamed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Vancomycin A Review of Population Pharmacokinetic Analyses
Amelie Marsot et al.
CLINICAL PHARMACOKINETICS (2012)
Maturation of the Glomerular Filtration Rate in Neonates, as Reflected by Amikacin Clearance
Roosmarijn F. W. De Cock et al.
CLINICAL PHARMACOKINETICS (2012)
The Use of Antifungal Therapy in Neonatal Intensive Care
Daniela Testoni et al.
CLINICS IN PERINATOLOGY (2012)
The Use of Antiviral Drugs During the Neonatal Period
Richard J. Whitley
CLINICS IN PERINATOLOGY (2012)
Pharmacokinetics of Drugs in Neonates: Pattern Recognition Beyond Compound Specific Observations
Anne Smits et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Pediatric Vancomycin Use in 421 Hospitals in the United States, 2008
Tamar Lasky et al.
PLOS ONE (2012)
Trough Concentrations of Vancomycin Adult Therapeutic Targets Are Not Appropriate for Children
Claire L. Gordon et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
COMMENTARY: PEDIATRIC ANTIFUNGAL DRUG DEVELOPMENT LESSONS LEARNED AND RECOMMENDATIONS FOR THE FUTURE
Kevin M. Watt et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
THERAPEUTIC MONITORING OF VORICONAZOLE IN CHILDREN LESS THAN THREE YEARS OF AGE: A CASE REPORT AND SUMMARY OF VORICONAZOLE CONCENTRATIONS FOR TEN CHILDREN
Elizabeth H. Doby et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Defining Risk Factors for Red Man Syndrome in Children and Adults
Angela L. Myers et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Epidemiology, Risk Factors and Outcome of Candida parapsilosis Bloodstream Infection in Children
John Dotis et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Antifungal Therapy and Outcomes in Infants With Invasive Candida Infections
Simon B. Ascher et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Management of Neonates With Suspected or Proven Early-Onset Bacterial Sepsis
Richard A. Polin
PEDIATRICS (2012)
Treatment and Prophylaxis of Invasive Candidiasis
Nidhi Tripathi et al.
SEMINARS IN PERINATOLOGY (2012)
Comment: Assessment of Vancomycin Dosing and Subsequent Serum Concentrations in Pediatric Patients
Sylvain Goutelle et al.
ANNALS OF PHARMACOTHERAPY (2011)
Assessment of Vancomycin Dosing and Subsequent Serum Concentrations in Pediatric Patients
Lea S. Eiland et al.
ANNALS OF PHARMACOTHERAPY (2011)
Population Pharmacokinetics and Pharmacodynamics of Caspofungin in Pediatric Patients
Chi-Chung Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Refining Vancomycin Protein Binding Estimates: Identification of Clinical Factors That Influence Protein Binding
Jill M. Butterfield et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Empirical treatment of neonatal sepsis: are the current guidelines adequate?
B. Muller-Pebody et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2011)
Vancomycin prescription in neonates and young infants: toward a simplified dosage
C. Oudin et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2011)
Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding
Souzan B. Yanni et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2011)
Vancomycin Therapeutic Guidelines: Closer Examination of Neonatal Pharmacokinetics
Sander Croes et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy - is there a 'right' choice?
Anna Turkova et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Echinocandin Antifungal Drugs in Fungal Infections A Comparison
Sharon C. -A. Chen et al.
DRUGS (2011)
Pharmacokinetics of antifungal agents in children
Kevin Watt et al.
EARLY HUMAN DEVELOPMENT (2011)
Voriconazole plasma levels in children are highly variable
I. Spriet et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Getting the dose of vancomycin right in the neonate
John N. van den Anker
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units
S. Kadambari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes
David W. Kimberlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Fluconazole Loading Dose Pharmacokinetics and Safety in Infants
Lauren Piper et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Delayed Acyclovir Therapy and Death Among Neonates With Herpes Simplex Virus Infection
Samir S. Shah et al.
PEDIATRICS (2011)
Impact of a Hospitalwide Increase in Empiric Pediatric Vancomycin Dosing on Initial Trough Concentrations
Adam Frymoyer et al.
PHARMACOTHERAPY (2011)
Therapeutic Drug Monitoring of Voriconazole After Intravenous Administration in Infants and Children With Primary Immunodeficiency
Magdalena Gerin et al.
THERAPEUTIC DRUG MONITORING (2011)
An Evaluation of Initial Vancomycin Dosing in Infants, Children, and Adolescents
Laura Broome et al.
INTERNATIONAL JOURNAL OF PEDIATRICS (2011)
Pharmacokinetics of Cefotaxime and Desacetylcefotaxime in Infants during Extracorporeal Membrane Oxygenation
Maurice J. Ahsman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Population Pharmacokinetics of Micafungin in Neonates and Young Infants
William W. Hope et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline
Maria-Remedios Marques-Minana et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants
D. K. Benjamin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Prediction of Vancomycin Pharmacodynamics in Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections: A Monte Carlo Simulation
Adam Frymoyer et al.
CLINICAL THERAPEUTICS (2010)
Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity
K. Niimi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Breakthrough Invasive Candidiasis in Patients on Micafungin
Christopher D. Pfeiffer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Clinical Characteristics, Outcomes, and Microbiologic Features Associated with Methicillin-Resistant Staphylococcus aureus Bacteremia in Pediatric Patients Treated with Vancomycin
Kerry J. Welsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Discrepancies between predicted and observed rates of intravenous gentamicin delivery for neonates
Catherine M.T. Sherwin et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Extended-interval gentamicin: Population pharmacokinetics in pediatric critical illness
Sara Arenas Lopez et al.
PEDIATRIC CRITICAL CARE MEDICINE (2010)
Clinical Pharmacokinetics of Penicillins, Cephalosporins and Aminoglycosides in the Neonate: A Review
Gian Maria Pacifici
PHARMACEUTICALS (2010)
Neonatal liver abscesses due to Candida infection effectively treated with caspofungin
Luca Filippi et al.
ACTA PAEDIATRICA (2009)
Pharmacokinetic comparison of nomogram-based and individualized vancomycin regimens in neonates
Trey Crumby et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers
Michael Neely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age
Xavier Saez-Llorens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies
Mats O. Karlsson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
In Vitro Activities of Fluconazole and Voriconazole against Clinical Isolates of Candida spp. Determined by Disk Diffusion Testing in Turin, Italy
Narcisa Mandras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species
Paul A. Mann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Evaluation of the Effect of Intravenous Volume Expanders upon the Volume of Distribution of Gentamicin in Septic Neonates
Catherine M. T. Sherwin et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2009)
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
Ina Scholz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Developmental Pharmacokinetics of Gentamicin in Preterm and Term Neonates Population Modelling of a Prospective Study
Elisabet I. Nielsen et al.
CLINICAL PHARMACOKINETICS (2009)
Clinical Trials in Neonates: A Therapeutic Imperative
R. M. Ward et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Daniel J. Diekema et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection
G. Lombardi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Efficacy and safety of a single daily dose of gentamicin in hospitalized Indian children: a quasi-randomized trial
Soumya Tiwari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies
Lauren Nassetta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system
Sara E. Oliver et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Refractory neonatal candidemia and high-dose micafungin pharmacotherapy
G. Natarajan et al.
JOURNAL OF PERINATOLOGY (2009)
Nephrotoxicity Associated With Amphotericin B Deoxycholate in Neonates
Jennifer Le et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Fluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young Infants
Kelly C. Wade et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates
P. Brian Smith et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Current Recommended Dosing of Vancomycin for Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections Is Inadequate
Adam Frymoyer et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Influence of sodium intake on Amphotericin B-induced nephrotoxicity among extremely premature infants
Rodica Turcu et al.
PEDIATRIC NEPHROLOGY (2009)
Pharmacokinetic Outcomes of a Simplified, Weight-Based, Extended-Interval Gentamicin Dosing Protocol in Critically III Neonates
David S. Hoff et al.
PHARMACOTHERAPY (2009)
Antivirals for Cytomegalovirus Infection in Neonates and Infants
Beth C. Marshall et al.
PEDIATRIC DRUGS (2009)
Population Pharmacokinetics of Fluconazole in Young Infants
K. C. Wade et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates
A. Chantal Caviness et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2008)
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease
David W. Kimberlin et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Observational Trial of a 48-Hour Gentamicin Dosing Regimen Derived from Monte Carlo Simulations in Infants Born at Less than 28 Weeks' Gestation
Erik S. Thingvoll et al.
JOURNAL OF PEDIATRICS (2008)
In defense of empiric acyclovir therapy in certain neonates
Sarah S. Long
JOURNAL OF PEDIATRICS (2008)
When should you initiate acyclovir therapy in a neonate?
David W. Kimberlin
JOURNAL OF PEDIATRICS (2008)
Pediatric Antifungal Utilization New Drugs, New Trends
Priya A. Prasad et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant
A. Mueller et al.
JOURNAL OF PERINATOLOGY (2008)
Determination of extended-interval gentamicin dosing for neonatal patients in developing countries
Gary L. Darmstadt et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation
E. P. Acosta et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Valganciclovir for congenital CMV infection: A pilot study on plasma concentration in newborns and infants
Luisa Galli et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Prevention and treatment of Candida infections in neonates
Rachel L. Chapman
SEMINARS IN PERINATOLOGY (2007)
Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance
Brian J. Anderson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants
Gloria P. Heresi et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Acute effects of gentamicin on glomerular and tubular functions in preterm neonates
Sevinc Tugay et al.
PEDIATRIC NEPHROLOGY (2006)
Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection
P. S. Buonuomo et al.
JOURNAL OF PERINATOLOGY (2006)
Valganciclovir for treatment of congenital cytomegalovirus infection
Sven Schulzke et al.
EUROPEAN JOURNAL OF PEDIATRICS (2006)
Population pharmacokinetics of gentamicin in premature newborns
Benito Garcia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants
C. Michael Cotten et al.
PEDIATRICS (2006)
Correlation of MIC with outcome for Candida species tested against voriconazole:: Analysis and proposal for interpretive breakpoints
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Caspofungin for refractory candidemia in neonates
S Manzar et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Interaction of zwitterionic penicillins with the OmpF channel facilitates their translocation
C Danelon et al.
BIOPHYSICAL JOURNAL (2006)
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1
Sergey V. Balashov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death
RH Clark et al.
PEDIATRICS (2006)
Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months
DK Benjamin et al.
PEDIATRICS (2006)
Population pharmacokinetics of amphotericin B lipid complex in neonates
G Würthwein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
New antifungal agents under development in children and neonates
WJ Steinbach et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2005)
Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction
MF Hebert et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Seventy-five years of neonatal sepsis at Yale: 1928-2003
MJ Bizzarro et al.
PEDIATRICS (2005)
Safety, tolerability, and pharmacokinetics of micafungin (FK463) in febrile neutropenic pediatric patients
NL Seibel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates
S Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit
CM Healy et al.
JOURNAL OF PEDIATRICS (2005)
New dosing strategies for antibacterial agents in the neonate
M de Hoog et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2005)
The effect of sepsis upon gentamicin pharmacokinetics in neonates
M Lingvall et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Disposition of caspofungin: Role of distribution in determining pharmacokinetics in plasma
JA Stone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates
JM Lanao et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection
BJ Stoll et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants
B Holler et al.
PEDIATRICS (2004)
Vancomycin - Pharmacokinetics and administration regimens in neonates
M de Hoog et al.
CLINICAL PHARMACOKINETICS (2004)
Pharmacodynamic functions: A multiparameter approach to the design of antibiotic treatment regimens
RR Regoes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Population pharmacokinetics of gentamicin in South African newborns
JH Botha et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Antifungal pharmacotherapy for neonatal candidiasis
JM Bliss et al.
SEMINARS IN PERINATOLOGY (2003)
Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations
N Linder et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
The effect of postnatal age on gentamicin pharmacokinetics in neonates
JA Knight et al.
PHARMACOTHERAPY (2003)
Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya
AH Thomson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system:: A randomized, controlled trial
DW Kimberlin et al.
JOURNAL OF PEDIATRICS (2003)
A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates
R DiCenzo et al.
PHARMACOTHERAPY (2003)
Effect of serologic status and Cesarean delivery on transmission rates of herpes simplex virus from-mother to infant
ZA Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Risk of resistant infections with Enterobacteriaceae in hospitalized neonates
N Singh et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit
P Toltzis et al.
PEDIATRICS (2002)
Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates
LML Stolk et al.
THERAPEUTIC DRUG MONITORING (2002)
Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network
BJ Stoll et al.
PEDIATRICS (2002)
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
MA Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Valganciclovir: An advance in cytomegalovirus therapeutics
JM Cocohoba et al.
ANNALS OF PHARMACOTHERAPY (2002)
A comparative study of plasma concentrations of liposomal amphotericin B (L-AMP-LRC-1) in adults, children and neonates
RN Kotwani et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
TJ Walsh et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Comparison of two gentamicin dosing schedules in very low birth weight infants
A Rastogi et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans
I Bekersky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
An extended interval dosing method for gentamicin in neonates
MD Stickland et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Vancomycin, teicoplanin, and ramoplanin: Synthetic and mechanistic studies
DL Boger
MEDICINAL RESEARCH REVIEWS (2001)
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections
DW Kimberlin et al.
PEDIATRICS (2001)
Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections
AH Groll et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
Gentamicin pharmacokinetics in preterm infants with a patent and a closed ductus arteriosus
DJ Touw et al.
PHARMACY WORLD & SCIENCE (2001)
Oral ganciclovir in children: Pharmacokinetics, safety, tolerance, and antiviral effects
LM Frenkel et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Lipid amphotericin preparations
KM Williams et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Systemic Candida infection in extremely low birth weight infants:: short term morbidity and long term neurodevelopmental outcome
S Friedman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Risk factors for candidemia in neonatal intensive care unit patients
L Saiman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Vancomycin population pharmacokinetics in neonates
M de Hoog et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
The kinetic profile of gentamicin in premature neonates
MJ Rocha et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
Share Paper
